Join this webinar for a panel discussion and Q&A reflecting on ideas offered in a forthcoming report by the Sabin-Aspen Vaccine Science & Policy Group, Powering Vaccine R&D: Opportunities for Transformation. This report will draw on historic lessons learned from vaccine development to outline opp...
Join this webinar for a panel discussion and Q&A reflecting on ideas offered in a forthcoming report by the Sabin-Aspen Vaccine Science & Policy Group, Powering Vaccine R&D: Opportunities for Transformation. This report will draw on historic lessons learned from vaccine development to outline opportunities to overhaul vaccine R&D practices to better prepare for the next pandemic, to make strides against diseases currently without vaccines, and to establish next-generation vaccines that offer meaningful improvements.
FEATURING:
Brief overview of report by Dr. Bruce Gellin, President of Global Immunization, Sabin Vaccine Institute; member, Sabin-Aspen Vaccine Science & Policy Group
Panel discussion moderated by Jamie Bay Nishi, Director, Global Health Technologies Coalition (GHTC), featuring: • Dr. Kundai Chinyenze, Executive Medical Director, IAVI, Uganda • Dr. Penny Heaton, Chief Executive Officer, Bill & Melinda Gates Medical Research Institute; member, Sabin-Aspen Vaccine Science & Policy Group • Dr. John Nkengasong, Director, Africa Centres for Disease Control and Prevention • Prof. Helen Rees, Executive Director, Wits Reproductive Health and HIV Institute, University of the Witwatersrand; member, Sabin-Aspen Vaccine Science & Policy Group
